# David S. Knopman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-s-knopman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 171,621 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 187 |
| i10-index | 1,017 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5059027860 |
| ORCID iD | https://orcid.org/0000-0002-6544-066X |
| Works | 2,056 |

## Researcher papers

Showing 12 of 27.

- [Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia](https://scholariq.org/papers/sensitivity-of-revised-diagnostic-criteria-for-the-behavioural-variant-of/)
- [Classification of primary progressive aphasia and its variants](https://scholariq.org/papers/classification-of-primary-progressive-aphasia-and-its-variants/)
- [Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS](https://scholariq.org/papers/expanded-ggggcc-hexanucleotide-repeat-in-noncoding-region-of-c9orf72-causes/)
- [Primary age-related tauopathy (PART): a common pathology associated with human aging](https://scholariq.org/papers/primary-age-related-tauopathy-part-a-common-pathology-associated-with-human/)
- [Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis](https://scholariq.org/papers/early-role-of-vascular-dysregulation-on-late-onset-alzheimer-s-disease-based-on/)
- [The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics](https://scholariq.org/papers/the-mayo-clinic-study-of-aging-design-and-sampling-participation-baseline/)
- [Prevalence of mild cognitive impairment is higher in men](https://scholariq.org/papers/prevalence-of-mild-cognitive-impairment-is-higher-in-men/)
- [Cognitive impairment in hemodialysis patients is common](https://scholariq.org/papers/cognitive-impairment-in-hemodialysis-patients-is-common/)
- [Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs](https://scholariq.org/papers/development-of-cognitive-instruments-for-use-in-clinical-trials-of-antidementia/)
- [Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition](https://scholariq.org/papers/association-between-midlife-vascular-risk-factors-and-estimated-brain-amyloid/)
- [Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort](https://scholariq.org/papers/associations-between-midlife-vascular-risk-factors-and-25-year-incident-dementia/)
- [Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease](https://scholariq.org/papers/spread-of-pathological-tau-proteins-through-communicating-neurons-in-human/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Advanced Neuroimaging Techniques and Applications](https://scholariq.org/topics/advanced-neuroimaging-techniques-and-applications/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.